Image

Enhancing Lung Cancer Screening Through Human-Centered Intervention

Enhancing Lung Cancer Screening Through Human-Centered Intervention

Recruiting
50-80 years
All
Phase N/A

Powered by AI

Overview

The purpose of this study is to further understand the factors involved in increasing lung cancer screening.

Description

The study aims to identify patient, primary care team and health system factors that facilitate participation in lung cancer screening. Additionally, conduct a two-arm randomized comparative effectiveness intervention study to increase lung cancer screening compared with a usual care control arm and further evaluate the differential impact of the intervention conditions compared to usual care.

Eligibility

Inclusion Criteria:

Interviews
  • UC Davis Health Systems (UCDHS) primary care providers and clinic staff who provide services to patients ages 50-80.
  • Patients who are eligible for lung cancer screening.

Screening Intervention:

  • Patients ages 50-80 who have a history of smoking per review of their electronic medical record and who receive care at the following UCDH ambulatory care clinics: Ellison Ambulatory Care Clinic; Elk Grove; Midtown.

Exclusion Criteria:

Interviews
  • Non-consenting patients and patients who do not speak English or Spanish
  • Patients aged 49 and younger
  • Non UCDHS primary care providers and clinic staff

Screening Intervention:

  • UCDHS patients who have already received Lung Cancer Screening
  • Patients with existing Cancer diagnosis

Study details
    Lung Cancer

NCT06351085

University of California, Davis

15 April 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.